Bronchial mucosal immunoreactivity of sensory neuropeptides in severe airway diseases

American Journal of Respiratory and Critical Care Medicine

Volumn 158, Issue 3, 1998, Pages 985-990

  Chanez, Pascal ^a   Springall, David ^b   Vignola, Antonio M ^b   Moradoghi Hattvani, Anne ^b   Polak, Julia M ^b   Godard, Philippe ^b   Bousquet, Jean ^b  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; NEUROPEPTIDE; SUBSTANCE P; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; ASTHMA; BRONCHUS BIOPSY; BRONCHUS MUCOSA; BRONCHUS REACTIVITY; CHRONIC BRONCHITIS; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; MALE; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE;

EID: 0031753366     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.158.3.9608104     Document Type: Article

References (35)

1. Laitinen, A. 1985. Autonomic innervation of the human respiratory tract as revealed by histochemical and ultrastructural methods. Eur. J. Respir. Dis. 140(Suppl.):1-42.
2. Hislop, A. A., J. Wharton, K. M. Allen, J. M. Polak, and S. G. Haworth. 1990. Immunohistochemical localization of peptide-containing nerves in human airways: age-related changes. Am. J. Respir. Cell Mol. Biol. 3:191-198.
3. Luts, A., R. Uddman, P. Alm, J. Basterra, and F. Sundler. 1993. Peptide-containing nerve fibers in human airways: distribution and coexistence pattern. Int. Arch. Allergy Immunol. 101:52-60.
4. Baraniuk, J. N., J. D. Lundgren, J. H. Shelhamer, and M. A. Kaliner. 1992. Gastrin releasing peptide (GRP) binding sites in human bronchi. Neuropeptides 21:81-84.
5. Fischer, A., W. Kummer, J. Y. Couraud, D. Adler, D. Branscheid, and C. Heym. 1992. Immunohistochemical localization of receptors for vasoactive intestinal peptide and substance P in human trachea. Lab. Invest. 67:387-393.
6. Ollerenshaw, S., D. Jarvis, A. Woolcock, C. Sullivan, and T. Scheibner. 1989. Absence of immunoreactive vasoactive intestinal polypeptide in tissue from the lungs of patients with asthma. N. Engl. J. Med. 320: 1244-1248.
7. Howarth, P., D. Springall, T. Redington, R. Djukanovic, S. Holgate, and J. Polak. 1995. Neuropeptide containing nerves in endobronchial biopsies from asthmatic and non-asthmatic subjects. Am. J. Respir. Cell Mol. Biol. 13:288-297.
8. Ollerenshaw, S. L., D. Jarvis, C. E. Sullivan, and A. J. Woolcock. 1991. Substance P immunoreactive nerves in airways from asthmatics and nonasthmatics. Eur. Respir. J. 4:673-682.
9. Cardell, L. O., R. Uddman, and L. Edvinsson. 1994. Low plasma concentrations of VIP and elevated levels of other neuropeptides during exacerbations of asthma. Eur. Respir. J. 7:2169-2173.
10. Barnes, P. J. 1992. Neurogenic inflammation and asthma. J. Asthma 29: 165-180.
11. Joos, G. F., P. R. Germonpre, J. C. Kips, R. A. Peleman, and R. A. Pauwels. 1994. Sensory neuropeptides and the human lower airways: present state and future directions. Eur. Respir. J. 1161-1171.
12. Gross, N. J. 1988. The use of anticholinergic agents in the treatment of airways disease. Clin. Chest Med. 9:591-598.
13. Bousquet, J., P. Chanez, J. Y. Lacoste, G. Barneon, N. Ghavanian, I. Enander, P. Venge, S. Ahlstedt, J. Simony-Lafontaine, P. Godard, and F. B. Michel. 1990. Eosinophilic inflammation in asthma. N. Engl. J. Med. 323:1033-1039.
14. Lacoste, J. Y., J. Bousquet, P. Chanez, T. Van-Vyve, J. Simony-Lafontaine, N. Lequeu, P. Vic, I. Enander, P. Godard, and F. B. Michel. 1993. Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. J. Allergy Clin. Immunol. 92:537-548.
15. Aas, K. 1981. Heterogeneity of bronchial asthma. Allergy 36:3-10.
16. Vignola, A. M., A. M. Campbell, P. Chanez, J. Bousquet, P. Paul-Lacoste, F. B. Michel, and P. Godard. 1993. HLA-DR and ICAM-1 expression on bronchial epithelial cells in asthma and chronic bronchitis. Am. Rev. Respir. Dis. 148:689-694.
17. Robinson, D. S., S. Ying, A. M. Bentley, Q. Meng, J. North, S. R. Durham, A. B. Kay, and Q. Hamid. 1993. Relationships among numbers of bronchoalveolar lavage cells expressing messenger ribonucleic acid for cytokines, asthma symptoms, and airway methacholine responsiveness in atopic asthma. J. Allergy Clin. Immunol. 92:397-403.
18. Knudson, R., R. Slavin, M. Lebowitz, and B. Burrows. 1976. The maximum expiratory flow volume curve: normal standards, variability and effects of age. Am. Rev. Respir. Dis. 113:587-600.
19. Bosken, C. H., J. Hards, K. Gatter, and J. C. Hogg. 1992. Characterization of the inflammatory reaction in the peripheral airways of cigarette smokers using immunocytochemistry. Am. Rev. Respir. Dis. 145: 911-917.
20. Cadieux, A., D. R. Springall, P. K. Mulderry, J. Rodrigo, M. A. Ghatei, G. Terenghi, S. R. Bloom, and J. M. Polak. 1986, Occurrence, distribution and ontogeny of CGRP immunoreactivity in the rat lower respiratory tract: effect of capsaicin treatment and surgical denervations. Neuroscience 19:605-627.
21. Cowen, T., A. J. Haven, and G. Burnstock. 1985. Pontamine sky blue: a counterstain for background autofluorcscence in fluorescence and immunofluorescence histochemistry. Histochemistry 82:205-208.
22. Gulbenkian, S., J. Wharton, and J. M. Polak. 1987. The visualisation of cardiovascular innervation in the guinea pig using an antiserum to protein gene product 9.5 (PGP 9.5). J. Auton. Nerv. Syst. 18:235-247.
23. Thompson, R. J., J. F. Doran, P. Jackson, A. P. Dhillon, and J. Rode. 1983. PGP 9.5 - a new market for vertebrate neurons and neuroendocrine cells. Brain Res. 278:224-228.
24. Springall, D. R., J. M. Polak, L. Howard, R. F. Power, T. Krausz, S. Manickam, N. R. Banner, A. Khagani, M. Rose, and M. H. Yacoub. 1990. Persistence of intrinsic neurones and possible phenotypic changes after extrinsic denervation of human respiratory tract by heart-lung transplantation. Am. Rev. Respir. Dis. 141:1538-1546.
25. Woolcock, A. J. 1993. Steroid resistant asthma: what is the clinical definition? Eur. Respir. J. 6:743-747.
26. Lammers, J. W., P. J. Barnes, and K. F. Chung. 1992. Nonadrenergic, noncholinergic airway inhibitory nerves. Eur. Respir. J. 5:239-246.
27. Nadel, J. A. 1992. Neurogenic inflammation in airways and its modulation by peptidases. Ann. NY Acad. Sci. 664:408-414.
28. Lilly, C. M., J. M. Drazen, and S. A. Shore. 1993. Peptidasc modulation of airway effects of neuropeptides. Proc. Soc. Exp. Biol. Med. 203:388-404.
29. Lilly, C., T. Bai, S. Shore, A. Hall, and J. Drazen. 1995. Neuropeptide content of lungs from asthmatic and nonasthmatic patients. Am. J. Respir. Crit. Care Med. 151:548-553.
30. Tomaki, M., M. Ichinose, M. Miura, Y. Hirayama, H. Yamauchi, N. Nakajima, and K. Shirato. 1995. Elevated substance P content in induced sputum from patients with asthma and patients with chronic bronchitis. Am. J. Respir. Crit. Care Med. 151:613-617.
31. Fujiwara, H., N. Kurihara, K. Hirata, K. Ohta, H. Kanazawa, and T. Takeda. 1993. Effect of neuropeptide Y on human bronchus and its modulation of neutral endopeptidase. J. Allergy Clin. Immunol. 92:89-94.
32. Merten, M. D., and C. Figarella. 1994. Neuropeptide Y and norepinephrine cooperatively inhibit human tracheal gland cell secretion. Am. J. Physiol. 266:L513-L518.
33. Takahashi, T., M. Ichinose, H. Yamauchi, M. Miura, N. Nakajima, J. Ishikawa, H. Inoue, T. Takishima, and K. Shirato. 1993. Neuropeptide Y inhibits neurogenic inflammation in guinea pig airways. J. Appl. Physiol. 75:103-107.
34. O'Connell, F., D. R. Springall, A. Moradoghli-Haftvani, T. Krausz, D. Price, R. W. Fuller, J. M. Polak, and N. B. Pride. 1995. Abnormal intraepithelial airway nerves in persistent unexplained cough? Am. J. Respir. Crit. Care Med. 152:2068-2075.
35. Merighi, A., J. M. Polak, S. J. Gibson, S. Gulbenkian, K. L. Valentino, and S. M. Peirone. 1988. Ultrastructural studies on calcitonin gene-related peptide-tachykinins- and somatostatin-immunoreactive neurones in rat dorsal root ganglia: evidence for the colocalization of different peptides in single secretory granules. Cell Tissue Res. 254: 101-109.